BBR Partners’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
EC
5VM
BCM
FCM
AVLSA
ACM
BBR Partners's TECX Position: Q2 2024 in Review
BBR Partners sold out of Tectonic Therapeutic (TECX) in Q2 2024, closing a stake of 5,000 shares — an estimated $76.8K sold.
BBR Partners first reported a position in TECX in Q3 2023 and held it in 3 quarters. The position peaked at $92.4K in Q3 2023. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2024.
- BBR Partners reported no remaining Tectonic Therapeutic position as of Q2 2024 after selling out during the quarter.
- BBR Partners sold 5,000 Tectonic Therapeutic shares in Q2 2024, an estimated $76.8K.
- BBR Partners first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 3 quarters.
- BBR Partners's Tectonic Therapeutic position peaked at $92.4K in Q3 2023.
- 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2024.
Based on BBR Partners's 13F filing for Q2 2024, filed 5 Aug 2024.